What is Quest Diagnostics's D&A?

Quest Diagnostics (DGX) reported D&A of $37M in Q1 2026.

How has Quest Diagnostics's D&A changed year-over-year?

Quest Diagnostics's D&A decreased by 5.1% year-over-year, from $39M to $37M.

What is the long-term trend for Quest Diagnostics's D&A?

Over 4 years (2021 to 2025), Quest Diagnostics's D&A has grown at a 10.6% compound annual growth rate (CAGR), from $103M to $154M.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

Quest Diagnostics DGX D&A

D&A at other companies

Labcorp HoldingsLH

$75.6M+8.6%

Opko HealthOPK

$18.97M-4.5%

Fulgent Genetics, Inc.FLGT

$2.03M+2.1%

QuidelOrtho CorporationQDEL

$112.9M+5.4%

Natera, Inc.NTRA

——

RevvityRVTY

——

Segments

By segment

See full

DIS business$106M+9.3%

General corporate activities$38M-2.6%

All other operating segments$3M-25.0%

Other financials

Income statement

See full

Revenue$2.9B+9.2%

Gross profit$942.0M+9.2%

Operating income$399.0M+15.3%

Net income$252.0M+14.5%

EPS (diluted)$2.24+15.5%

Balance sheet

See full

Cash & equivalents$393.0M+109%

Total debt$6.4B-2.5%

Total equity$7.4B+6.3%

Total assets$16.7B+5.5%

Cash flow

See full

Operating cash flow$278.0M-11.5%

CapEx$114.0M-2.6%

Free cash flow$164.0M-16.8%

Valuation

See full

Market cap$23.46B+20.8%

Enterprise value$29.48B+15.7%

P/E22.9×+2.5×

P/S2.1×+0.2×

Profitability

See full

Gross margin33.2%+0.4pp

Operating margin14.3%+0.6pp

Net margin9.1%+0.2pp

FCF margin11.8%+1.4pp

Returns & leverage

See full

Return on equity14.3%+0.9pp

Debt / equity0.9×-0.1×

Current ratio1.2×-0.3×

Where this comes from

Reported directly by Quest Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Quest Diagnostics’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quest Diagnostics's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Quest Diagnostics's D&A?: Quest Diagnostics (DGX) reported D&A of $37M in Q1 2026.
How has Quest Diagnostics's D&A changed year-over-year?: Quest Diagnostics's D&A decreased by 5.1% year-over-year, from $39M to $37M.
What is the long-term trend for Quest Diagnostics's D&A?: Over 4 years (2021 to 2025), Quest Diagnostics's D&A has grown at a 10.6% compound annual growth rate (CAGR), from $103M to $154M.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.